Evidence map›Paper›PMID 27593926›Full record

ReviewOncogene2017

Autophagy in cancer metastasis.

E E Mowers, M N Sharifi, K F Macleod

Open access · bronzeAbstract readReview
In one paragraph

Review in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 277 papers.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed
36.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 480 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Autophagy in Ovarian Cancer, an Opportunity or an Additional Threat?International journal of molecular sciences · 2026
    Review
  9. Article
  10. Review
  11. Dammarolic acid improves tyrosine kinase inhibitor activity in lung cancer cells.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  12. Article
  13. Article
  14. The potential role of hydrogen sulfide-autophagy axis in diseases.Journal of physiology and biochemistry · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

E E MowersThe Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
M N SharifiThe Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
K F MacleodThe Ben May Department for Cancer Research, The University of Chicago, Chicago, IL, USA.
University of Chicago · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinomaR01CA200310 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD · 2016 to 2026
$3.6M
Autophagy in Tumor Progression and MetastasisR01CA162405 · NCI · UNIVERSITY OF CHICAGO · PI MACLEOD, KAY F · 2012 to 2016
$1.6M
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancerR01CA216242 · NCI · UNIVERSITY OF CHICAGO · PI MACLEOD, KAY F · 2017 to 2021
$1.6M
NCI NIH HHS R01 CA162405NCI NIH HHS R01 CA200310NCI NIH HHS R01 CA216242NCI NIH HHS T32 CA009594NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

Autophagy is a highly conserved self-degradative process that has a key role in cellular stress responses and survival. Recent work has begun to explore the function of autophagy in cancer metastasis, which is of particular interest given the dearth of effective therapeutic options for metastatic disease. Autophagy is induced upon progression of various human cancers to metastasis and together with data from genetically engineered mice and experimental metastasis models, a role for autophagy at nearly every phase of the metastatic cascade has been identified. Specifically, autophagy has been shown to be involved in modulating tumor cell motility and invasion, cancer stem cell viability and differentiation, resistance to anoikis, epithelial-to-mesenchymal transition, tumor cell dormancy and escape from immune surveillance, with emerging functions in establishing the pre-metastatic niche and other aspects of metastasis. In this review, we provide a general overview of how autophagy modulates cancer metastasis and discuss the significance of new findings for disease management.

Indexed as

AutophagyAnimalsAnoikisCell CycleCell MovementEpithelial-Mesenchymal TransitionGene Expression RegulationHumansImmunologic SurveillanceNeoplasm MetastasisNeoplasmsNeoplastic Stem CellsSignal TransductionTumor EscapeTumor Microenvironment

Identifiers

PMID27593926
PMCPMC5337449
OpenAlexW2513393093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.